首页 > 最新文献

Urology Annals最新文献

英文 中文
Survival rate comparisons of angioembolization and neoadjuvant targeted therapy on unresectable renal cell carcinoma patients: A systematic review. 血管栓塞术与新辅助靶向疗法对不可切除肾细胞癌患者生存率的比较:系统综述。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_114_23
Rifqi Yanda Muhammad, Derri Hafa Nurfajri, Dahril Dahril, Jufriady Ismy

Objective: Renal cell cancer (RCC) is the most typical form of kidney cancer in adults, which accounts for 80% to 85% of all primary renal neoplasms. RCC develops inside the renal cortex. This study aimed to systematically review the survival rate of patients treated with targeted therapy and/or RC. Surgery is the standard therapy for RCC, even though after surgery, 20%-40% of patients with localized RCC would experience distant metastases. Metastases or large RCC are not amenable to surgery. Unresectable RCC can be treated palliatively with angioembolization or neoadjuvant therapy. This study aims to review the survival rate comparisons of angioembolization and neoadjuvant targeted therapy on unresectable renal cell carcinoma.

Methods: A thorough search across databases such as PubMed, Cochrane Library, and ProQuest was conducted for articles published from 2018 to 2023. To uphold research integrity, duplicates, reviews, and incomplete articles were excluded, ensuring only pertinent and original research findings for subsequent analysis.

Results: Database search yielded 247 articles, which were systematically eliminated, leaving 6 relevant articles. Analyzed articles showed the overall survival of patients treated with angioembolization and neoadjuvant agents.

Conclusion: Unresectable RCC can be treated palliatively with angioembolization. Angioembolization may improve clinical effectiveness and lessen side effects by boosting local concentrations of drugs. Drug-eluting bead transarterial chemoembolization is a novel embolization option that can embolize the arteries that feed the tumor and cutoff the blood supply to the tumor. Sunitinib, the most studied medicinal agent, was found to have higher effectiveness when combined with angioembolization.

目的:肾细胞癌(RCC)是成人肾癌中最典型的一种,占所有原发性肾肿瘤的 80% 至 85%。RCC 在肾皮质内生长。本研究旨在系统回顾接受靶向治疗和/或RC治疗的患者的生存率。手术是治疗 RCC 的标准疗法,尽管在手术后,20%-40% 的局部 RCC 患者会出现远处转移。转移灶或巨大的 RCC 不适合手术治疗。无法切除的 RCC 可通过血管栓塞或新辅助疗法进行姑息治疗。本研究旨在回顾血管栓塞术和新辅助靶向疗法对不可切除肾细胞癌生存率的比较:在PubMed、Cochrane Library和ProQuest等数据库中对2018年至2023年发表的文章进行了全面检索。为维护研究的完整性,排除了重复、综述和不完整的文章,确保只有相关的原创性研究成果才能用于后续分析:数据库搜索共获得247篇文章,经过系统剔除,剩下6篇相关文章。分析文章显示了接受血管栓塞术和新辅助药物治疗的患者的总生存率:结论:无法切除的RCC可通过血管栓塞术进行姑息治疗。血管栓塞可提高药物在局部的浓度,从而改善临床疗效并减轻副作用。药物洗脱珠经动脉化疗栓塞术是一种新型栓塞方法,可栓塞肿瘤供血动脉,切断肿瘤的血液供应。研究发现,舒尼替尼作为研究最多的药物,在与血管栓塞术结合使用时具有更高的疗效。
{"title":"Survival rate comparisons of angioembolization and neoadjuvant targeted therapy on unresectable renal cell carcinoma patients: A systematic review.","authors":"Rifqi Yanda Muhammad, Derri Hafa Nurfajri, Dahril Dahril, Jufriady Ismy","doi":"10.4103/ua.ua_114_23","DOIUrl":"10.4103/ua.ua_114_23","url":null,"abstract":"<p><strong>Objective: </strong>Renal cell cancer (RCC) is the most typical form of kidney cancer in adults, which accounts for 80% to 85% of all primary renal neoplasms. RCC develops inside the renal cortex. This study aimed to systematically review the survival rate of patients treated with targeted therapy and/or RC. Surgery is the standard therapy for RCC, even though after surgery, 20%-40% of patients with localized RCC would experience distant metastases. Metastases or large RCC are not amenable to surgery. Unresectable RCC can be treated palliatively with angioembolization or neoadjuvant therapy. This study aims to review the survival rate comparisons of angioembolization and neoadjuvant targeted therapy on unresectable renal cell carcinoma.</p><p><strong>Methods: </strong>A thorough search across databases such as PubMed, Cochrane Library, and ProQuest was conducted for articles published from 2018 to 2023. To uphold research integrity, duplicates, reviews, and incomplete articles were excluded, ensuring only pertinent and original research findings for subsequent analysis.</p><p><strong>Results: </strong>Database search yielded 247 articles, which were systematically eliminated, leaving 6 relevant articles. Analyzed articles showed the overall survival of patients treated with angioembolization and neoadjuvant agents.</p><p><strong>Conclusion: </strong>Unresectable RCC can be treated palliatively with angioembolization. Angioembolization may improve clinical effectiveness and lessen side effects by boosting local concentrations of drugs. Drug-eluting bead transarterial chemoembolization is a novel embolization option that can embolize the arteries that feed the tumor and cutoff the blood supply to the tumor. Sunitinib, the most studied medicinal agent, was found to have higher effectiveness when combined with angioembolization.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"251-260"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of laparoscopic sacrocolpopexy using self-cut mesh on pelvic organ prolapse. 使用自切网片的腹腔镜骶骨整形术对盆腔脏器脱垂的疗效。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_142_21
Alfa Putri Meutia, Suskhan Djusad, Tyas Priyatini, Kevin Yonathan, Tokumasa Hayashi, Jimmy Nomura

Objectives: The objective of the study was to investigate the long-term outcome and complication rate of laparoscopic sacrocolpopexy (LSC) using self-cut mesh as pelvic organ prolapse treatment.

Methods: A retrospective cohort study on patients undergoing LSC was done at Kameda Medical Center from January 2013 to January 2018. Data for this study were taken from all women with pelvic organ prolapse who had undergone LSC using self-cut polypropylene mesh. Patients with a previous history of hysterectomy were excluded from the study. An evaluation was done preoperatively, on 6-month and 1-year postoperative follow-up period using Pelvic Organ Prolapse Quantification (POP-Q) and The International Consultation on Incontinence Questionnaire-short form (ICIQ-SF) questionnaire.

Results: There were 702 subjects who met the inclusion and exclusion criteria. The clinical characteristics of the subjects were recorded. The scores during admission, 6 months and 1 year postoperative are: POP Q scores: 6.50 ± 5.69 vs. 5.11 ± 4.85 vs. 4.78 ± 4.31, P = 0.049 and ICIQ SF scores: 2.92 ± 0.62 vs. 1.10 ± 0.36 vs. 1.13 ± 0.41, P < 0.001). A total of 17 (2.4%) perioperative and postoperative complications were observed on subjects.

Conclusion: LSC using self-cut mesh could produce satisfactory results in pelvic organ prolapse patients on 6-month and 1-year follow-up period with minimal perioperative complications.

研究目的该研究旨在调查使用自切网片作为盆腔器官脱垂治疗方法的腹腔镜骶骨整形术(LSC)的长期效果和并发症发生率:2013年1月至2018年1月,龟田医疗中心对接受LSC手术的患者进行了一项回顾性队列研究。本研究的数据来自所有使用自切聚丙烯网片接受 LSC 治疗的盆腔器官脱垂女性患者。曾接受过子宫切除术的患者不在研究范围内。使用盆腔器官脱垂定量法(POP-Q)和尿失禁国际咨询问卷简表(ICIQ-SF)对患者进行术前评估、术后 6 个月和 1 年随访:共有702名受试者符合纳入和排除标准。记录了受试者的临床特征。入院时、术后 6 个月和 1 年的得分分别为POP Q 评分6.50 ± 5.69 vs. 5.11 ± 4.85 vs. 4.78 ± 4.31,P = 0.049;ICIQ SF 评分:2.92 ± 0.62 vs. 1.10 ± 0.36 vs. 1.13 ± 0.41,P < 0.001)。受试者共观察到 17 例(2.4%)围术期和术后并发症:结论:在6个月和1年的随访中,使用自切网片的LSC可为盆腔器官脱垂患者带来令人满意的效果,且围术期并发症极少。
{"title":"Outcomes of laparoscopic sacrocolpopexy using self-cut mesh on pelvic organ prolapse.","authors":"Alfa Putri Meutia, Suskhan Djusad, Tyas Priyatini, Kevin Yonathan, Tokumasa Hayashi, Jimmy Nomura","doi":"10.4103/ua.ua_142_21","DOIUrl":"10.4103/ua.ua_142_21","url":null,"abstract":"<p><strong>Objectives: </strong>The objective of the study was to investigate the long-term outcome and complication rate of laparoscopic sacrocolpopexy (LSC) using self-cut mesh as pelvic organ prolapse treatment.</p><p><strong>Methods: </strong>A retrospective cohort study on patients undergoing LSC was done at Kameda Medical Center from January 2013 to January 2018. Data for this study were taken from all women with pelvic organ prolapse who had undergone LSC using self-cut polypropylene mesh. Patients with a previous history of hysterectomy were excluded from the study. An evaluation was done preoperatively, on 6-month and 1-year postoperative follow-up period using Pelvic Organ Prolapse Quantification (POP-Q) and The International Consultation on Incontinence Questionnaire-short form (ICIQ-SF) questionnaire.</p><p><strong>Results: </strong>There were 702 subjects who met the inclusion and exclusion criteria. The clinical characteristics of the subjects were recorded. The scores during admission, 6 months and 1 year postoperative are: POP Q scores: 6.50 ± 5.69 vs. 5.11 ± 4.85 vs. 4.78 ± 4.31, <i>P</i> = 0.049 and ICIQ SF scores: 2.92 ± 0.62 vs. 1.10 ± 0.36 vs. 1.13 ± 0.41, <i>P</i> < 0.001). A total of 17 (2.4%) perioperative and postoperative complications were observed on subjects.</p><p><strong>Conclusion: </strong>LSC using self-cut mesh could produce satisfactory results in pelvic organ prolapse patients on 6-month and 1-year follow-up period with minimal perioperative complications.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"284-287"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587938/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does tilt-retrograde intrarenal surgery enhance stone clearance and offer better surgical ergonomics in patients with renal calculi? A prospective randomized control study. 倾斜逆行肾内手术能否提高结石清除率,并为肾结石患者提供更好的手术工效?一项前瞻性随机对照研究。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_44_24
Arvind Ramachandran, Vivek Meyyappan, Hariharasudhan Sekar, Gayathri Thiruvengadam, Sriram Krishnamoorthy

Introduction: Retrograde intrarenal surgery (RIRS) is the standard treatment for renal calculi. Direct visualization and fragmentation are its major advantages. The variable stone clearance rates and the ergonomic challenges faced by urologists are a few limitations. Table tilt enhances stone clearance and improves surgical ergonomics by facilitating better access to stones and reducing procedural strain.

Subjects and methods: In this prospective study, patients with intrarenal calculi were randomized into standard lithotomy RIRS (S-RIRS) and table-tilted RIRS (T-RIRS) groups. Specified table tilts were suggested for each of the stone locations. The outcomes with regard to stone clearance, operative and lasing time, and ergonomics were studied.

Results: About 100 patients were studied, with 50 in each group. The overall operating time and lasing time in the T-RIRS group were less than that in the S-RIRS group (P < 0.001). The complication rates were the same in both groups. Most surgeons felt that the surgical ergonomics was better in the T-RIRS group (P < 0.001). When stone-free status was analyzed, seven patients in the S-RIRS group and one in the T-RIRS group had residual stones. The mean Borg category-ratio 10 (CR-10) scores in the S-RIRS and T-RIRS groups were 4.18 and 2.20, respectively (P < 0.001).

Conclusions: This is the first study to document the distinct advantages of T-RIRS and its benefits on surgical ergonomics. T-RIRS resulted in significantly shorter operative and lasing times, particularly for stones in lower calyces. Surgical ergonomics, assessed by the Borg CR-10 scale, were significantly better in the T-RIRS group. T-RIRS should become a standard of care for patients undergoing RIRS.

简介:逆行肾内手术(RIRS)是治疗肾结石的标准方法:逆行肾内手术(RIRS)是治疗肾结石的标准方法。直接观察和碎石是其主要优点。结石清除率不稳定以及泌尿科医生面临的人体工程学挑战是其局限性。倾斜手术台可提高结石清除率,并通过更好地接触结石和减少手术劳损来改善手术工效学:在这项前瞻性研究中,肾内结石患者被随机分为标准碎石RIRS(S-RIRS)组和桌面倾斜RIRS(T-RIRS)组。针对每种结石位置都建议了特定的桌面倾斜度。研究了结石清除、手术和激光时间以及人体工程学方面的结果:研究了约 100 名患者,每组 50 人。T-RIRS 组的总手术时间和激光时间均少于 S-RIRS 组(P < 0.001)。两组的并发症发生率相同。大多数外科医生认为 T-RIRS 组的手术工效更好(P < 0.001)。在分析无结石状态时,S-RIRS 组和 T-RIRS 组分别有 7 名和 1 名患者有残余结石。S-RIRS组和T-RIRS组的博格分类比率10(CR-10)平均得分分别为4.18和2.20(P < 0.001):这是第一项记录 T-RIRS 独特优势及其对手术工效的益处的研究。T-RIRS大大缩短了手术时间和套管时间,尤其是对于下盏结石。根据博格 CR-10 量表评估,T-RIRS 组的手术工效明显更好。T-RIRS 应成为接受 RIRS 的患者的标准护理方法。
{"title":"Does tilt-retrograde intrarenal surgery enhance stone clearance and offer better surgical ergonomics in patients with renal calculi? A prospective randomized control study.","authors":"Arvind Ramachandran, Vivek Meyyappan, Hariharasudhan Sekar, Gayathri Thiruvengadam, Sriram Krishnamoorthy","doi":"10.4103/ua.ua_44_24","DOIUrl":"10.4103/ua.ua_44_24","url":null,"abstract":"<p><strong>Introduction: </strong>Retrograde intrarenal surgery (RIRS) is the standard treatment for renal calculi. Direct visualization and fragmentation are its major advantages. The variable stone clearance rates and the ergonomic challenges faced by urologists are a few limitations. Table tilt enhances stone clearance and improves surgical ergonomics by facilitating better access to stones and reducing procedural strain.</p><p><strong>Subjects and methods: </strong>In this prospective study, patients with intrarenal calculi were randomized into standard lithotomy RIRS (S-RIRS) and table-tilted RIRS (T-RIRS) groups. Specified table tilts were suggested for each of the stone locations. The outcomes with regard to stone clearance, operative and lasing time, and ergonomics were studied.</p><p><strong>Results: </strong>About 100 patients were studied, with 50 in each group. The overall operating time and lasing time in the T-RIRS group were less than that in the S-RIRS group (<i>P</i> < 0.001). The complication rates were the same in both groups. Most surgeons felt that the surgical ergonomics was better in the T-RIRS group (<i>P</i> < 0.001). When stone-free status was analyzed, seven patients in the S-RIRS group and one in the T-RIRS group had residual stones. The mean Borg category-ratio 10 (CR-10) scores in the S-RIRS and T-RIRS groups were 4.18 and 2.20, respectively (<i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>This is the first study to document the distinct advantages of T-RIRS and its benefits on surgical ergonomics. T-RIRS resulted in significantly shorter operative and lasing times, particularly for stones in lower calyces. Surgical ergonomics, assessed by the Borg CR-10 scale, were significantly better in the T-RIRS group. T-RIRS should become a standard of care for patients undergoing RIRS.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"306-314"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationale of restaging transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer in the current era. 非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术重新分期的理论依据。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_50_24
Amit Sharma, R T Raghavendra, Deepak Biswal, Pradhuman Yadav, Saryu Goel, Satyadeo Sharma

Background: We present retrospective data of patients with nonmuscle invasive bladder cancer (NMIBC) who underwent restaging transurethral resection of bladder tumor (Re-TURBT) at a tertiary care center.

Materials and methods: Records of all NMIBC patients undergoing Re-TURBT between March 2021 and September 2023 were retrospectively analyzed. Patients were risk stratified based on TURBT pathology. Re-TURBT was performed between 4 and 6 weeks. Adverse features such as number, size, and appearance were noted. Patients with persistent disease at Re-TURBT were counseled for early cystectomy with urinary diversion or intravesical Bacillus Calmette-Guerin (BCG). In case of disease upstaging, patients were counseled for radical cystectomy.

Results: Thirty-eight NMIBC patients (30 males and 8 females) underwent Re-TURBT. Six patients had residual/persistent disease at 6 weeks, all high risk and high grade (HG, P value not significant, P = 0.31). There was no association with number and appearance of tumors with residual/persistence at 6 weeks. The mean lesion size on imaging in cases with and without residual disease was 3.32 ± 0.86 versus 3.39 ± 0.92 cm, respectively, P value not significant (0.868). There was no residual disease in the low-grade (LG) pT1 group, but HG pTa and pT1 (n = 3) had residual disease. Four HG pT1 patients opted for early cystectomy. Two patients each had pT0 and two pT2. At 3 months of follow-up, urethral strictures were seen both in high risk and intermediate risk. Among four patients who had stricture, meatal stenosis was common (50%, n = 2). Two patients had long-segment stricture requiring perineal urethrostomy with stage I Johannsen repair. All HG pT1 lesion patients eventually underwent cystectomy (3 were under staged and two treated completely with TURBT, one with TURBT + BCG and one patient progressed to metastasis).

Conclusion: Re-TURBT is essential for the management of HG pTa and HG pT1 lesions for accurate staging and treatment of residual disease. However, LG pT1 patients can safely be excluded from Re-TURBT.

背景:我们提供了在一家三级医疗中心接受再分期经尿道膀胱肿瘤切除术(Re-TURBT)的非肌浸润性膀胱癌(NMIBC)患者的回顾性数据:回顾性分析了2021年3月至2023年9月期间接受Re-TURBT手术的所有NMIBC患者的记录。根据TURBT病理学对患者进行了风险分层。再TURBT在4至6周之间进行。记录了不良特征,如数量、大小和外观。对再次进行 TURBT 时病情仍未缓解的患者,建议其尽早进行膀胱切除术,同时进行尿路改道或膀胱内卡介苗(BCG)注射。如果病情进一步恶化,则建议患者进行根治性膀胱切除术:38名NMIBC患者(30男8女)接受了Re-TURBT治疗。6名患者在6周时出现残留/持续性疾病,均为高危和高级别(HG,P值不显著,P = 0.31)。肿瘤的数量和外观与6周时的残留/存留没有关系。有残留病灶和无残留病灶病例的影像学平均病灶大小分别为 3.32 ± 0.86 厘米和 3.39 ± 0.92 厘米,P 值无显著性差异(0.868)。低级别(LG)pT1 组没有残留病灶,但 HG pTa 和 pT1(n = 3)有残留病灶。4 名 HG pT1 患者选择了早期膀胱切除术。pT0 和 pT2 患者各两名。在 3 个月的随访中,高危和中危患者都出现了尿道狭窄。在四名尿道狭窄患者中,肉腔狭窄很常见(50%,n = 2)。两名患者出现了长段尿道狭窄,需要进行会阴尿道造口术和 I 期约翰森修补术。所有HG pT1病变患者最终都接受了膀胱切除术(3例患者分期不足,2例患者完全接受了TURBT治疗,1例患者接受了TURBT+卡介苗治疗,1例患者进展为转移):结论:对 HG pTa 和 HG pT1 病变进行再 TURBT 治疗对于准确分期和治疗残余疾病至关重要。然而,LG pT1 患者可以安全地排除在 Re-TURBT 治疗之外。
{"title":"Rationale of restaging transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer in the current era.","authors":"Amit Sharma, R T Raghavendra, Deepak Biswal, Pradhuman Yadav, Saryu Goel, Satyadeo Sharma","doi":"10.4103/ua.ua_50_24","DOIUrl":"10.4103/ua.ua_50_24","url":null,"abstract":"<p><strong>Background: </strong>We present retrospective data of patients with nonmuscle invasive bladder cancer (NMIBC) who underwent restaging transurethral resection of bladder tumor (Re-TURBT) at a tertiary care center.</p><p><strong>Materials and methods: </strong>Records of all NMIBC patients undergoing Re-TURBT between March 2021 and September 2023 were retrospectively analyzed. Patients were risk stratified based on TURBT pathology. Re-TURBT was performed between 4 and 6 weeks. Adverse features such as number, size, and appearance were noted. Patients with persistent disease at Re-TURBT were counseled for early cystectomy with urinary diversion or intravesical Bacillus Calmette-Guerin (BCG). In case of disease upstaging, patients were counseled for radical cystectomy.</p><p><strong>Results: </strong>Thirty-eight NMIBC patients (30 males and 8 females) underwent Re-TURBT. Six patients had residual/persistent disease at 6 weeks, all high risk and high grade (HG, <i>P</i> value not significant, <i>P</i> = 0.31). There was no association with number and appearance of tumors with residual/persistence at 6 weeks. The mean lesion size on imaging in cases with and without residual disease was 3.32 ± 0.86 versus 3.39 ± 0.92 cm, respectively, <i>P</i> value not significant (0.868). There was no residual disease in the low-grade (LG) pT1 group, but HG pTa and pT1 (<i>n</i> = 3) had residual disease. Four HG pT1 patients opted for early cystectomy. Two patients each had pT0 and two pT2. At 3 months of follow-up, urethral strictures were seen both in high risk and intermediate risk. Among four patients who had stricture, meatal stenosis was common (50%, <i>n</i> = 2). Two patients had long-segment stricture requiring perineal urethrostomy with stage I Johannsen repair. All HG pT1 lesion patients eventually underwent cystectomy (3 were under staged and two treated completely with TURBT, one with TURBT + BCG and one patient progressed to metastasis).</p><p><strong>Conclusion: </strong>Re-TURBT is essential for the management of HG pTa and HG pT1 lesions for accurate staging and treatment of residual disease. However, LG pT1 patients can safely be excluded from Re-TURBT.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"288-291"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility, efficacy, and safety of retrograde intrarenal surgery in <1-year age group: A single-center experience. 1 岁以下儿童逆行肾内手术的可行性、有效性和安全性:单中心经验。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_119_23
Chandra Mohan Vaddi, Hemnath Anandan, Paidakula Ramakrishna, P M Siddalinga Swamy, Soundarya Ganesan, Rakesh Panda

Purpose: Urolithiasis in infants is uncommon. Percutaneous nephrolithotomy, extracorporeal shockwave lithotripsy, and retrograde intrarenal surgery (RIRS) are the management options. RIRS is the least studied of these options in infants. In our series of 23 cases, we aim to assess the feasibility, efficacy, and safety of RIRS in <1-year age group.

Materials and methods: This was a retrospective analysis of a series of 23 infants who underwent RIRS in our hospital from January 2018 to March 2021. Children who were <12 months of age and had the largest stone size of <20 mm were included in the study.

Results: Twenty-three patients (male - 15; female - 8) were included in the study. The mean age was 10 ± 2.31 months (range, 4-12 months). The mean stone size was 11.6 ± 2.96 mm (range, 7.5-19 mm). The mean operative time was 29.44 ± 7.45 min (range, 17-42 min). Six patients (22.2%) had mild hematuria (Clavien I), and seven patients (25.9%) had postoperative fever. Stone size had a significant positive correlation with laser time, operative time, and intraoperative intravasation, but no significant association with stone-free rate. At 2-month follow-up, 4 (three patients) out of 27 renal units had residual stones (stone-free rate [SFR] - 85.1%). No patient had long-term complications like urethral or ureteric stricture or stone recurrence during the given follow-up period.

Conclusion: RIRS is a feasible and minimally invasive treatment for renal stones in infants with acceptable SFRs.

目的:婴儿尿路结石并不常见。治疗方法包括经皮肾镜碎石术、体外冲击波碎石术和逆行肾内手术(RIRS)。其中,逆行肾内手术对婴儿的研究最少。在我们的 23 例系列研究中,我们旨在评估 RIRS 在婴儿中的可行性、有效性和安全性:这是对 2018 年 1 月至 2021 年 3 月在我院接受 RIRS 的 23 例婴儿的系列回顾性分析。的患儿:23例患者(男-15例;女-8例)被纳入研究。平均年龄为 10±2.31 个月(范围为 4-12 个月)。结石平均大小为 11.6 ± 2.96 毫米(范围为 7.5-19 毫米)。平均手术时间为(29.44±7.45)分钟(17-42分钟不等)。六名患者(22.2%)出现轻度血尿(Clavien I),七名患者(25.9%)术后发烧。结石大小与激光时间、手术时间和术中出血量呈显著正相关,但与无结石率无显著关联。在两个月的随访中,27 个肾单位中有 4 个(3 名患者)有残余结石(无结石率 [SFR] - 85.1%)。在随访期间,没有患者出现尿道或输尿管狭窄或结石复发等长期并发症:结论:RIRS 是一种可行的微创婴儿肾结石治疗方法,无石率可接受。
{"title":"Feasibility, efficacy, and safety of retrograde intrarenal surgery in <1-year age group: A single-center experience.","authors":"Chandra Mohan Vaddi, Hemnath Anandan, Paidakula Ramakrishna, P M Siddalinga Swamy, Soundarya Ganesan, Rakesh Panda","doi":"10.4103/ua.ua_119_23","DOIUrl":"10.4103/ua.ua_119_23","url":null,"abstract":"<p><strong>Purpose: </strong>Urolithiasis in infants is uncommon. Percutaneous nephrolithotomy, extracorporeal shockwave lithotripsy, and retrograde intrarenal surgery (RIRS) are the management options. RIRS is the least studied of these options in infants. In our series of 23 cases, we aim to assess the feasibility, efficacy, and safety of RIRS in <1-year age group.</p><p><strong>Materials and methods: </strong>This was a retrospective analysis of a series of 23 infants who underwent RIRS in our hospital from January 2018 to March 2021. Children who were <12 months of age and had the largest stone size of <20 mm were included in the study.</p><p><strong>Results: </strong>Twenty-three patients (male - 15; female - 8) were included in the study. The mean age was 10 ± 2.31 months (range, 4-12 months). The mean stone size was 11.6 ± 2.96 mm (range, 7.5-19 mm). The mean operative time was 29.44 ± 7.45 min (range, 17-42 min). Six patients (22.2%) had mild hematuria (Clavien I), and seven patients (25.9%) had postoperative fever. Stone size had a significant positive correlation with laser time, operative time, and intraoperative intravasation, but no significant association with stone-free rate. At 2-month follow-up, 4 (three patients) out of 27 renal units had residual stones (stone-free rate [SFR] - 85.1%). No patient had long-term complications like urethral or ureteric stricture or stone recurrence during the given follow-up period.</p><p><strong>Conclusion: </strong>RIRS is a feasible and minimally invasive treatment for renal stones in infants with acceptable SFRs.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"270-276"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Our experience of laparoscopic vesicovaginal fistula repair in a tertiary care center. 我们在一家三级医疗中心进行腹腔镜膀胱阴道瘘修补术的经验。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_65_23
Ahsan Ahmad, Khalid Mahmood, Nikhil Ranjan, Md Zaid Imbisat, Rajesh Kumar Tiwari

Objective: Laparoscopic repair of vesicovaginal fistula (VVF) is gaining popularity day by day, but we have limited literature on it. This study is to evaluate the safety, feasibility, and outcomes of laparoscopic VVF repair in a tertiary care center in Eastern India.

Subjects and methods: This study is a single-center retrospective study in which 11 patients of supratrigonal VVF were evaluated who underwent laparoscopic repair. Preoperative workup included history, examination, computed tomography urography, cystoscopy, and vaginoscopy. After informed consent, laparoscopic VVF repair was done under general anesthesia. Duration of surgery, the need for conversion to open procedure, intraoperative bowel injury, the need for postoperative blood transfusion, postoperative hospital stay, postoperative urinary leak, and any incontinence after catheter removal were noted.

Results: All the patients had primary supratrigonal fistula of approximate size in the range of 1.5-2.0 cm. All the included patients were operated on successfully by laparoscopic technique with a mean duration of surgery of 177.91 ± 6.14 min. The mean duration of postoperative hospital stay was 4.45 ± 0.52 days. There was no incidence of postoperative urine leak in any patient. After urethral catheter removal, all the patients voided well without any incontinence.

Conclusions: Laparoscopic VVF repair is a safe and feasible option with satisfactory intraoperative and postoperative outcomes.

目的:腹腔镜下膀胱阴道瘘(VVF)修复术日渐流行,但相关文献却很有限。本研究旨在评估印度东部一家三级医疗中心的腹腔镜膀胱阴道瘘修补术的安全性、可行性和效果:本研究是一项单中心回顾性研究,共评估了 11 名接受腹腔镜修复术的三叉神经上VVF患者。术前检查包括病史、体格检查、计算机断层扫描尿路造影术、膀胱镜检查和阴道镜检查。知情同意后,在全身麻醉下进行腹腔镜 VVF 修复术。手术时间、是否需要转为开腹手术、术中肠道损伤、术后是否需要输血、术后住院时间、术后漏尿、拔除导尿管后是否出现尿失禁等情况均被记录在案:所有患者都患有原发性上肛瘘,大小约为 1.5-2.0 厘米。所有患者均成功接受了腹腔镜手术,平均手术时间为(177.91 ± 6.14)分钟。术后平均住院时间为(4.45±0.52)天。所有患者均未发生术后漏尿。拔除尿道导管后,所有患者均排尿顺畅,无任何尿失禁现象:腹腔镜 VVF 修复术是一种安全可行的选择,术中和术后效果令人满意。
{"title":"Our experience of laparoscopic vesicovaginal fistula repair in a tertiary care center.","authors":"Ahsan Ahmad, Khalid Mahmood, Nikhil Ranjan, Md Zaid Imbisat, Rajesh Kumar Tiwari","doi":"10.4103/ua.ua_65_23","DOIUrl":"10.4103/ua.ua_65_23","url":null,"abstract":"<p><strong>Objective: </strong>Laparoscopic repair of vesicovaginal fistula (VVF) is gaining popularity day by day, but we have limited literature on it. This study is to evaluate the safety, feasibility, and outcomes of laparoscopic VVF repair in a tertiary care center in Eastern India.</p><p><strong>Subjects and methods: </strong>This study is a single-center retrospective study in which 11 patients of supratrigonal VVF were evaluated who underwent laparoscopic repair. Preoperative workup included history, examination, computed tomography urography, cystoscopy, and vaginoscopy. After informed consent, laparoscopic VVF repair was done under general anesthesia. Duration of surgery, the need for conversion to open procedure, intraoperative bowel injury, the need for postoperative blood transfusion, postoperative hospital stay, postoperative urinary leak, and any incontinence after catheter removal were noted.</p><p><strong>Results: </strong>All the patients had primary supratrigonal fistula of approximate size in the range of 1.5-2.0 cm. All the included patients were operated on successfully by laparoscopic technique with a mean duration of surgery of 177.91 ± 6.14 min. The mean duration of postoperative hospital stay was 4.45 ± 0.52 days. There was no incidence of postoperative urine leak in any patient. After urethral catheter removal, all the patients voided well without any incontinence.</p><p><strong>Conclusions: </strong>Laparoscopic VVF repair is a safe and feasible option with satisfactory intraoperative and postoperative outcomes.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"266-269"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive preoperative cultures but not bacterial species predict postoperative urine culture results after holmium laser enucleation of the prostate. 钬激光前列腺去核术后尿液培养结果的预测因素是术前培养阳性而非细菌种类。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_31_24
Karen M Doersch, Timothy D Campbell, Ashley Li, Rajat K Jain, Scott O Quarrier

Purpose: The purpose of this study was to evaluate risk factors associated with positive urine cultures following holmium laser enucleation of the prostate (HoLEP).

Materials and methods: The data from a prospectively maintained database were analyzed to evaluate urine culture results following HoLEP and determine the contribution of predefined variables (age, prostate size, Charlson comorbidity score, surgical time [surrogate for case difficulty], the presence of a catheter preoperatively, postoperative urinary retention, and preoperative positive culture) on urine culture positivity at 60 days postoperatively. Statistical analyses included logistic regression and ANOVA.

Results: The data from 136 subjects were included in the database and were evaluated at a median of 13.37 ± 6.72 months after their HoLEP. Postoperative positive cultures were noted in 23 subjects (16.91%). Preoperative positive cultures were found to predict positive postoperative urine cultures (odds ratio: 3.78, confidence interval: 1.18-12.78, P = 0.03). However, the preoperative and postoperative results were discordant in 9 of 14 subjects with both positive preoperative and postoperative cultures.

Conclusions: Positive preoperative cultures were predictive of positive postoperative cultures. However, the pre- and postoperative results were often discordant. Host factors increasing susceptibility to bacteriuria may explain these findings.

目的:本研究旨在评估与前列腺钬激光去核术(HoLEP)后尿培养阳性相关的风险因素:对前瞻性数据库中的数据进行分析,评估钬激光前列腺剜除术后的尿培养结果,并确定预定义变量(年龄、前列腺大小、Charlson合并症评分、手术时间[病例难度的替代指标]、术前是否使用导尿管、术后尿潴留和术前尿培养阳性)对术后60天尿培养阳性率的影响。统计分析包括逻辑回归和方差分析:数据库共收录了 136 名受试者的数据,并对他们进行了评估,评估时间中位数为 HoLEP 术后 13.37±6.72 个月。术后培养阳性者有 23 人(16.91%)。术前培养阳性可预测术后尿培养阳性(几率比:3.78,置信区间:1.18-12.78,P = 0.03)。然而,在 14 例术前和术后培养均呈阳性的受试者中,有 9 例的术前和术后结果不一致:结论:术前培养阳性可预测术后培养阳性。结论:术前培养阳性可预测术后培养阳性,但术前和术后结果往往不一致。宿主因素增加了细菌尿的易感性,这可能是这些发现的原因。
{"title":"Positive preoperative cultures but not bacterial species predict postoperative urine culture results after holmium laser enucleation of the prostate.","authors":"Karen M Doersch, Timothy D Campbell, Ashley Li, Rajat K Jain, Scott O Quarrier","doi":"10.4103/ua.ua_31_24","DOIUrl":"10.4103/ua.ua_31_24","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to evaluate risk factors associated with positive urine cultures following holmium laser enucleation of the prostate (HoLEP).</p><p><strong>Materials and methods: </strong>The data from a prospectively maintained database were analyzed to evaluate urine culture results following HoLEP and determine the contribution of predefined variables (age, prostate size, Charlson comorbidity score, surgical time [surrogate for case difficulty], the presence of a catheter preoperatively, postoperative urinary retention, and preoperative positive culture) on urine culture positivity at 60 days postoperatively. Statistical analyses included logistic regression and ANOVA.</p><p><strong>Results: </strong>The data from 136 subjects were included in the database and were evaluated at a median of 13.37 ± 6.72 months after their HoLEP. Postoperative positive cultures were noted in 23 subjects (16.91%). Preoperative positive cultures were found to predict positive postoperative urine cultures (odds ratio: 3.78, confidence interval: 1.18-12.78, <i>P</i> = 0.03). However, the preoperative and postoperative results were discordant in 9 of 14 subjects with both positive preoperative and postoperative cultures.</p><p><strong>Conclusions: </strong>Positive preoperative cultures were predictive of positive postoperative cultures. However, the pre- and postoperative results were often discordant. Host factors increasing susceptibility to bacteriuria may explain these findings.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"292-295"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients. 伴有下腔静脉血栓的肾细胞癌:手术治疗患者的存活率和预后因素。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_113_23
Miguel Miranda, Joana Polido, Miguel Fernandes, Filipe Lopes, Tiago Oliveira, Tomé Lopes, Luís Costa, Ângelo Nobre, Tito Palmela Leitão, Luís Mendes Pedro, José Palma Dos Reis

Introduction: Renal cell carcinoma (RCC) often develops a tumor thrombus extending into the inferior vena cava (IVC). Radical nephrectomy with IVC thrombectomy is the standard treatment, although prognostic factors are yet to be properly established.

Objectives: The objectives of this study were to review the clinicopathological features of surgically treated patients with RCC and IVC thrombus and to investigate potential prognostic factors.

Materials and methods: This retrospective analysis covered patients with RCC and IVC thrombus who underwent surgical treatment at a tertiary center over 12 years.

Results: Of the 32 patients included, 56% and 41% had nodal (N1) and metastatic (M1) diseases, respectively. Thrombus level was 1 in 25% and 4 in 21.9% of cases, according to the Mayo classification. The median follow-up was 17.0 months. The median overall survival (OS) was 20.0 months, with a median OS of 36.0 months in M0 patients and 10.0 months in M1 patients (log-rank P = 0.029). Stage IV disease (T4 and/or M1 status) (hazard ratio [HR]: 2.85, P = 0.021), fat invasion (HR: 2.52, P = 0.044), positive margins (HR: 2.54, P = 0.037), American Society of Anesthesiologists score (HR: 2.59, P = 0.033), tumor size >100 mm (HR: 2.538, P = 0.033), and higher neutrophil-to-lymphocyte ratio (r 2 = 0.304, P = 0.001) were significantly associated with worse OS in univariate analysis. Thrombus level did not impact prognosis.

Conclusions: Certain clinicopathological factors, but not thrombus level, appear to influence prognosis. Prospective multicentric randomized studies are needed to better stratify patient risk, improve prognostic prediction, and evaluate systemic therapy responses.

导言:肾细胞癌(RCC)通常会形成延伸至下腔静脉(IVC)的肿瘤血栓。根治性肾切除术并行 IVC 血栓切除术是标准治疗方法,但预后因素尚未明确:本研究旨在回顾RCC和IVC血栓手术治疗患者的临床病理特征,并探讨潜在的预后因素:这项回顾性分析涵盖了12年来在一家三级中心接受手术治疗的RCC和IVC血栓患者:在纳入的32名患者中,分别有56%和41%患有结节性(N1)和转移性(M1)疾病。根据梅奥分类法,25%的病例血栓水平为1级,21.9%的病例血栓水平为4级。中位随访时间为17.0个月。中位总生存期(OS)为20.0个月,其中M0患者的中位OS为36.0个月,M1患者的中位OS为10.0个月(log-rank P = 0.029)。IV 期疾病(T4 和/或 M1 状态)(危险比 [HR]:2.85,P = 0.021)、脂肪侵犯(HR:2.52,P = 0.044)、边缘阳性(HR:2.54,P = 0.037)、美国麻醉医师协会评分(HR:2.59,P = 0.033)、肿瘤大小 >100 mm(HR:2.538,P = 0.033)、中性粒细胞与淋巴细胞比值较高(r 2 = 0.304,P = 0.001)在单变量分析中与较差的 OS 显著相关。血栓水平对预后没有影响:结论:某些临床病理因素(而非血栓水平)似乎会影响预后。需要进行前瞻性多中心随机研究,以更好地对患者进行风险分层、改善预后预测并评估系统治疗反应。
{"title":"Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients.","authors":"Miguel Miranda, Joana Polido, Miguel Fernandes, Filipe Lopes, Tiago Oliveira, Tomé Lopes, Luís Costa, Ângelo Nobre, Tito Palmela Leitão, Luís Mendes Pedro, José Palma Dos Reis","doi":"10.4103/ua.ua_113_23","DOIUrl":"10.4103/ua.ua_113_23","url":null,"abstract":"<p><strong>Introduction: </strong>Renal cell carcinoma (RCC) often develops a tumor thrombus extending into the inferior vena cava (IVC). Radical nephrectomy with IVC thrombectomy is the standard treatment, although prognostic factors are yet to be properly established.</p><p><strong>Objectives: </strong>The objectives of this study were to review the clinicopathological features of surgically treated patients with RCC and IVC thrombus and to investigate potential prognostic factors.</p><p><strong>Materials and methods: </strong>This retrospective analysis covered patients with RCC and IVC thrombus who underwent surgical treatment at a tertiary center over 12 years.</p><p><strong>Results: </strong>Of the 32 patients included, 56% and 41% had nodal (N1) and metastatic (M1) diseases, respectively. Thrombus level was 1 in 25% and 4 in 21.9% of cases, according to the Mayo classification. The median follow-up was 17.0 months. The median overall survival (OS) was 20.0 months, with a median OS of 36.0 months in M0 patients and 10.0 months in M1 patients (log-rank <i>P</i> = 0.029). Stage IV disease (T4 and/or M1 status) (hazard ratio [HR]: 2.85, <i>P</i> = 0.021), fat invasion (HR: 2.52, <i>P</i> = 0.044), positive margins (HR: 2.54, <i>P</i> = 0.037), American Society of Anesthesiologists score (HR: 2.59, <i>P</i> = 0.033), tumor size >100 mm (HR: 2.538, <i>P</i> = 0.033), and higher neutrophil-to-lymphocyte ratio (<i>r</i> <sup>2</sup> = 0.304, <i>P</i> = 0.001) were significantly associated with worse OS in univariate analysis. Thrombus level did not impact prognosis.</p><p><strong>Conclusions: </strong>Certain clinicopathological factors, but not thrombus level, appear to influence prognosis. Prospective multicentric randomized studies are needed to better stratify patient risk, improve prognostic prediction, and evaluate systemic therapy responses.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"277-283"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors and potential risk factors of iatrogenic ureteral injury following common obstetric and gynecological surgeries: A single-center retrospective study. 常见妇产科手术后输尿管先天性损伤的预测因素和潜在风险因素:单中心回顾性研究。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_25_24
Yahya Ghazwani, Nasser Albogami, Mohammed Aldwaighri, Ghassan Alhajress, Abdullah Alsaghyir, Faisal Balaraj

Objectives: As iatrogenic ureteral injury carries a high burden and is associated with increased postoperative morbidity and mortality, the purpose of this study is to determine the incidence and potential risk factors of iatrogenic ureteral injury following common obstetric and gynecological surgeries in King Abdulaziz Medical City.

Methods: This was a single-center retrospective cohort study based on data extracted from an electronic hospital information system conducted in King Abdulaziz Medical City, Riyadh, Saudi Arabia. Three thousand four hundred and sixty-four cases of cesarean section (C-section) and hysterectomy from January 1, 2021, to December 31, 2022, were reviewed. All cases of C-section and hysterectomy in which the urology department was consulted for suspected iatrogenic ureteric injuries were included in the study. All cases other than C-sections and hysterectomy in which the urology department was consulted for suspected iatrogenic ureteric injuries were excluded from the study.

Results: A total of 45 patients for whom urology was consulted for suspected ureteral injury were included in this study. Approximately (35.6%) one-third of the patients had positive findings of ureteral injury following common obstetric and gynecological surgeries. About 41.2% of these patients had previous gynecological surgeries. Other potential risk factors were tested such as age and body mass index. Older patients were slightly at higher risk of iatrogenic ureteral injury (P < 0.05).

Conclusion: Ureteral injury in obstetric and gynecological surgeries is rare yet serious complication. The findings of this study suggest that the incidence of iatrogenic ureteral injury was relatively associated with older age.

目的:由于先天性输尿管损伤的负担很重,且与术后发病率和死亡率的增加有关,本研究旨在确定阿卜杜勒阿齐兹国王医疗城常见妇产科手术后先天性输尿管损伤的发生率和潜在风险因素:这是一项基于沙特阿拉伯利雅得阿卜杜勒阿齐兹国王医疗城医院电子信息系统数据的单中心回顾性队列研究。研究回顾了2021年1月1日至2022年12月31日期间的3464例剖腹产(C-section)和子宫切除术病例。所有因怀疑输尿管先天性损伤而咨询泌尿科的剖腹产和子宫切除术病例均纳入研究范围。除剖腹产和子宫切除术外,所有因怀疑输尿管先天性损伤而咨询泌尿科的病例均不在研究范围内:本研究共纳入了 45 名因疑似输尿管损伤而就诊于泌尿科的患者。其中约(35.6%)三分之一的患者在接受普通妇产科手术后发现输尿管损伤。其中约 41.2% 的患者曾接受过妇科手术。还检测了其他潜在风险因素,如年龄和体重指数。年龄较大的患者发生先天性输尿管损伤的风险略高(P < 0.05):结论:妇产科手术中输尿管损伤是一种罕见但严重的并发症。本研究的结果表明,输尿管先天性损伤的发生率与年龄相对较大有关。
{"title":"Predictors and potential risk factors of iatrogenic ureteral injury following common obstetric and gynecological surgeries: A single-center retrospective study.","authors":"Yahya Ghazwani, Nasser Albogami, Mohammed Aldwaighri, Ghassan Alhajress, Abdullah Alsaghyir, Faisal Balaraj","doi":"10.4103/ua.ua_25_24","DOIUrl":"10.4103/ua.ua_25_24","url":null,"abstract":"<p><strong>Objectives: </strong>As iatrogenic ureteral injury carries a high burden and is associated with increased postoperative morbidity and mortality, the purpose of this study is to determine the incidence and potential risk factors of iatrogenic ureteral injury following common obstetric and gynecological surgeries in King Abdulaziz Medical City.</p><p><strong>Methods: </strong>This was a single-center retrospective cohort study based on data extracted from an electronic hospital information system conducted in King Abdulaziz Medical City, Riyadh, Saudi Arabia. Three thousand four hundred and sixty-four cases of cesarean section (C-section) and hysterectomy from January 1, 2021, to December 31, 2022, were reviewed. All cases of C-section and hysterectomy in which the urology department was consulted for suspected iatrogenic ureteric injuries were included in the study. All cases other than C-sections and hysterectomy in which the urology department was consulted for suspected iatrogenic ureteric injuries were excluded from the study.</p><p><strong>Results: </strong>A total of 45 patients for whom urology was consulted for suspected ureteral injury were included in this study. Approximately (35.6%) one-third of the patients had positive findings of ureteral injury following common obstetric and gynecological surgeries. About 41.2% of these patients had previous gynecological surgeries. Other potential risk factors were tested such as age and body mass index. Older patients were slightly at higher risk of iatrogenic ureteral injury (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>Ureteral injury in obstetric and gynecological surgeries is rare yet serious complication. The findings of this study suggest that the incidence of iatrogenic ureteral injury was relatively associated with older age.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"296-300"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of urolithiasis in Saudi Arabia: A systematic literature review. 沙特阿拉伯的尿路结石发病率:系统文献综述。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-16 DOI: 10.4103/ua.ua_29_24
Bandar A Alhubaishy, Omar A Bokhary, Majed A Alhuzali, Hanaa A Bokhary

Urolithiasis is a common urological disease that can have a negative impact on health and quality of life in people worldwide. Multiple studies have investigated the prevalence of urolithiasis worldwide. However, research on this disease in Saudi Arabia is very limited. This review was conducted to investigate the prevalence of urolithiasis and its associations in Saudi Arabia. A standardized, systematic search strategy was conducted to identify observational studies that reported the prevalence of urolithiasis in Saudi Arabia. The search included published studies between January 2000 and October 2023. A variation in prevalence between regions was found and was reported to range from 6% to 19%. A significant association between urolithiasis and two factors, increasing age and family history, was found. Studies on urolithiasis are limited in Saudi Arabia. Despite this, it is evident that the prevalence of urolithiasis is comparable in other parts of the world. Public awareness and lifestyle modification efforts may help reduce this disease's impact on our population.

泌尿系统结石是一种常见的泌尿系统疾病,会对全世界人民的健康和生活质量产生负面影响。多项研究调查了全球尿路结石的发病率。然而,沙特阿拉伯对该疾病的研究却非常有限。本综述旨在调查沙特阿拉伯的尿路结石发病率及其相关性。我们采用了标准化、系统化的搜索策略,以确定报告沙特阿拉伯尿路结石发病率的观察性研究。搜索范围包括 2000 年 1 月至 2023 年 10 月间发表的研究。结果发现,不同地区的发病率存在差异,据报道,发病率在 6% 到 19% 之间。研究发现,尿路结石与年龄增长和家族病史这两个因素之间存在明显关联。沙特阿拉伯对尿路结石的研究有限。尽管如此,尿路结石的发病率显然与世界其他地区相当。提高公众意识和改变生活方式可能有助于减少这种疾病对我国人口的影响。
{"title":"Prevalence of urolithiasis in Saudi Arabia: A systematic literature review.","authors":"Bandar A Alhubaishy, Omar A Bokhary, Majed A Alhuzali, Hanaa A Bokhary","doi":"10.4103/ua.ua_29_24","DOIUrl":"10.4103/ua.ua_29_24","url":null,"abstract":"<p><p>Urolithiasis is a common urological disease that can have a negative impact on health and quality of life in people worldwide. Multiple studies have investigated the prevalence of urolithiasis worldwide. However, research on this disease in Saudi Arabia is very limited. This review was conducted to investigate the prevalence of urolithiasis and its associations in Saudi Arabia. A standardized, systematic search strategy was conducted to identify observational studies that reported the prevalence of urolithiasis in Saudi Arabia. The search included published studies between January 2000 and October 2023. A variation in prevalence between regions was found and was reported to range from 6% to 19%. A significant association between urolithiasis and two factors, increasing age and family history, was found. Studies on urolithiasis are limited in Saudi Arabia. Despite this, it is evident that the prevalence of urolithiasis is comparable in other parts of the world. Public awareness and lifestyle modification efforts may help reduce this disease's impact on our population.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"16 4","pages":"261-265"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urology Annals
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1